Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Act-709478
2. N-(1-((5-cyanopyridin-2-yl)methyl)pyrazol-3-yl)-2-(4-(1-(trifluoromethyl)cyclopropyl)phenyl)acetamide
1. Act-709478
2. 1838651-58-3
3. 3z7u1u8z9e
4. N-(1-((5-cyanopyridin-2-yl)methyl)-1h-pyrazol-3-yl)-2-(4-(1-(trifluoromethyl)cyclopropyl)-phenyl)acetamide
5. Benzeneacetamide, N-[1-[(5-cyano-2-pyridinyl)methyl]-1h-pyrazol-3-yl]-4-[1-(trifluoromethyl)cyclopropyl]-
6. N-(1-((5-cyanopyridin-2-yl)methyl)pyrazol-3-yl)-2-(4-(1-(trifluoromethyl)cyclopropyl)phenyl)acetamide
7. N-[1-[(5-cyanopyridin-2-yl)methyl]pyrazol-3-yl]-2-[4-[1-(trifluoromethyl)cyclopropyl]phenyl]acetamide
8. Unii-3z7u1u8z9e
9. Chembl4217292
10. Schembl17316866
11. Bcp30302
12. Ex-a3130
13. Bdbm50452245
14. Akos037648975
15. Act 709478
16. Bs-16157
17. Hy-112723
18. Cs-0062884
19. Act709478; Act 709478
20. D80992
| Molecular Weight | 425.4 g/mol |
|---|---|
| Molecular Formula | C22H18F3N5O |
| XLogP3 | 3.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 6 |
| Exact Mass | 425.14634470 g/mol |
| Monoisotopic Mass | 425.14634470 g/mol |
| Topological Polar Surface Area | 83.6 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 693 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
ABOUT THIS PAGE
53
PharmaCompass offers a list of ACT-709478 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right ACT-709478 manufacturer or ACT-709478 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred ACT-709478 manufacturer or ACT-709478 supplier.
PharmaCompass also assists you with knowing the ACT-709478 API Price utilized in the formulation of products. ACT-709478 API Price is not always fixed or binding as the ACT-709478 Price is obtained through a variety of data sources. The ACT-709478 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A ACT 709478 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ACT 709478, including repackagers and relabelers. The FDA regulates ACT 709478 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ACT 709478 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A ACT 709478 supplier is an individual or a company that provides ACT 709478 active pharmaceutical ingredient (API) or ACT 709478 finished formulations upon request. The ACT 709478 suppliers may include ACT 709478 API manufacturers, exporters, distributors and traders.
ACT 709478 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of ACT 709478 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right ACT 709478 GMP manufacturer or ACT 709478 GMP API supplier for your needs.
A ACT 709478 CoA (Certificate of Analysis) is a formal document that attests to ACT 709478's compliance with ACT 709478 specifications and serves as a tool for batch-level quality control.
ACT 709478 CoA mostly includes findings from lab analyses of a specific batch. For each ACT 709478 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
ACT 709478 may be tested according to a variety of international standards, such as European Pharmacopoeia (ACT 709478 EP), ACT 709478 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ACT 709478 USP).
